Skip to main content

Table 1 Baseline characteristics of HIV-1 infected children starting ART in the MRC Paediatric HIV Cohort, The Gambia

From: Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa

Characteristics

HIV-1 (n = 65)

Male [No (%)]

34 (52.3%)

Female [No (%)]

31 (47.7%)

Age, years [median (IQR:)]

4.9 (2.2 – 9.1)

Age distribution [No. (%)]

 

 < 2 years

15 (23.1%)

 2 – 4 years

19 (29.2%)

 ≥ 5 years

31 (47.7%)

Parent status [No. (%)]

 

Both parents alive

34 (53.3%)

Only mother living

6 (9.2%)

Only father living

16 (24.6%)

Both parents dead

5 (7.7%)

Unknown

4 (6.2%)

WHO Paediatric Clinical stage [No. (%)]

 

 Stage 1

26 (40.6%)

 Stage 2

12 (18.5%)

 Stage 3

19 (29.2%)

 Stage 4

8 (12.3%)

Immunologic category (CD4+%) [No. (%)]

 

 >25%

1 (1.6%)

 15% – 25%

25 (39.7%)

 <15%

37 (58.7%)

Baseline CD4+% [median (IQR); n = 63 a]

13 (7 – 16)

 < 2 years (n = 14)

13 (6 – 16)

 2 – 4 years (n = 18)

14.5 (11 – 18)

 ≥ 5 years (n = 31)

10 (7 – 15)

Baseline CD4+ count [median (IQR); n = 62 b]

390 (210 – 730)

 < 2 years (n = 13)

510 (300 – 1100)

 2 – 4 years (n = 18)

615 (280 – 1020)

 ≥ 5 years (n = 31)

285 (100 – 520)

Baseline Viral load, log10copies/mL [median (IQR); n = 55c]

5.4 (4.5 – 6.0)

  1. a2 missing values; b3 missing values; c10 missing values.